MNZOManzo Pharmaceuticals, Inc.

About Manzo Pharmaceuticals, Inc. (MNZO)

Manzo Pharmaceuticals, Inc. (MNZO) is a Shell Companies company headquartered in Stouffville, ON, Canada whose shares trade over-the-counter on the Expert Market tier.

Manzo Pharmaceuticals, Inc. is without operations or a material amount of assets. The Issuer has conducted due dilligence, and has identified and is consumating a deal with www.directprivateoffers.ca, which is a Layer II, 'private over public' blockchain ICO and Crowdfunding platform. This ecosystem has been set up to do Intitial Coin Offerings that ascribe to the SEC's regulatory framework, with third party service providers. Ultimately, it is the objective to tokenize the issuer and offer an institutional grade security invested in precious metals, real estate, and issuers conducting ICOS. There is no assurance that the Issuer will be successful in this endeavor. A Shareholder's Meeting will be announced soon - to 'approve the acquisition', 'Regulation D #506 C Convertable Notes offers to Accredited Investors' and 'Plan of Reoganization'.

Products and services

In development.

MNZO key facts

Ticker symbol

MNZO

Market tier

Expert Market

Sector

Financial Services

Industry

Shell Companies

Headquarters

Stouffville, ON, Canada

Country of incorporation

US

Year of incorporation

1980

Employees

1

Estimated market cap

$110.0K (as of Apr 16, 2025)

Shares outstanding

1,099,522,000

Reporting standard

Dark: Alternative Reporting Standard

Audit status

Not Available

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2021)

Manzo Pharmaceuticals, Inc. leadership

• Arthur Douglas Smitherman — President, General Director

Explore more: Shell Companies stocks · Financial Services sector · Expert Market stocks · OTC stocks starting with M